Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/1999
12/02/1999WO1999061041A1 Novel peptides
12/02/1999WO1999060986A2 Apoptosis modulators that interact with the huntington's disease gene
12/02/1999WO1999060843A1 Transgenic plants producing a pap ii protein
12/02/1999WO1999060842A2 Plant retroelements and methods related thereto
12/02/1999WO1999060838A1 Organism and method for metal recovery, remediation and separation
12/02/1999WO1999055564A8 Materials and methods for gene therapy
12/02/1999WO1999053942A8 Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases
12/02/1999WO1999053091A9 Dna coding for gdnf, parts of said dna and gdnf variants
12/02/1999WO1999053082A3 Hexose carrier proteins
12/02/1999WO1999052941A3 Polypeptide domains capable of binding rho protein and their use in assays
12/02/1999WO1999052548A3 Conjugate vaccines for the prevention of dental caries
12/02/1999WO1999051745A3 Dna immunization against chlamydia infection
12/02/1999WO1999051725A3 Assay for the diagnosis of schizophrenia based on a new peptide
12/02/1999WO1999051268A9 Immunomodulatory compositions of mmtv antigens and methods of using same
12/02/1999WO1999050424A3 Fusion protein comprising a sequence from a major coat protein of a papovavirus
12/02/1999WO1999050413A3 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
12/02/1999WO1999050281A3 Collagen peptides and uses thereof
12/02/1999WO1999049059A3 Methods of cancer diagnosis using a chimeric toxin
12/02/1999WO1999048518A3 Medicament for preventing or treating papilloma virus-specific tumors
12/02/1999WO1999046381A9 Human fgf gene and gene expression products
12/02/1999WO1999045938B1 Thrombin preparation and products and fibrin sealant methods employing same
12/02/1999WO1999043703A8 Method for immunochemically assaying anti-hm1.24 antibody
12/02/1999WO1999043286A3 Isolated stromal cells for use in the treatment of diseases of the central nervous system
12/02/1999WO1999040115A3 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT
12/02/1999WO1999037661A9 Dna replication proteins of gram positive bacteria and their use to screen for chemical inhibitors
12/02/1999WO1999035262A3 Apoptosis inducing molecule ii
12/02/1999WO1999032634A3 Compositions derived from mycobacterium vaccae and methods for their use
12/02/1999WO1999019354A9 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
12/02/1999DE19824230A1 Neues Endometriose-assoziiertes Gen Create an endometriosis-associated gene
12/02/1999DE19823814A1 Verfahren zur Trennung und/oder Isolierung von Plasmaproteinen mit annularer Chromatographie A process for the separation and / or isolation of proteins with plasma of annular chromatography
12/02/1999CA2745939A1 Mara family helix-turn-helix domains and their methods of use
12/02/1999CA2745131A1 Aav5 vector and uses thereof
12/02/1999CA2372411A1 Method for separating and/or isolating plasma proteins by annular chromatography
12/02/1999CA2343317A1 Novel peptides
12/02/1999CA2333592A1 Methods of inhibiting clot formation
12/02/1999CA2333316A1 Method for separating and/or isolating plasma proteins by annularchromatography
12/02/1999CA2333281A1 Carotenoid ketolase genes and gene products, production of ketocarotenoids and methods of modifying carotenoids using the genes
12/02/1999CA2333167A1 Method for purification of borrelia lipoprotein ospa
12/02/1999CA2333159A1 Method
12/02/1999CA2333006A1 Calmodulin related protein
12/02/1999CA2331833A1 Parasite antigens
12/02/1999CA2329694A1 Kunitz domain polypeptide and materials and methods for making it
12/02/1999CA2329525A1 Cytokine resistant cytomegalovirus promoter mutants and related products and methods
12/02/1999CA2329506A1 Alg-2lp, alg-2 like molecules and uses therefor
12/02/1999CA2329505A1 Recombinant aav vectors for gene therapy of hemophilia a
12/02/1999CA2329274A1 Interleukin-21
12/02/1999CA2329269A1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
12/02/1999CA2329249A1 Apoptosis modulators that interact with the huntington's disease gene
12/02/1999CA2329157A1 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins
12/02/1999CA2329155A1 Interference with viral ires-mediated translation by a small yeast rna reveals critical rna-protein interactions
12/02/1999CA2329150A1 Transgenic plants producing a pap ii protein
12/02/1999CA2329143A1 Adeno-associated viral vector-mediated expression of factor viii activity
12/02/1999CA2329136A1 Oral immunization with papillomavirus virus-like particles
12/02/1999CA2329131A1 Method for recovering soluble protein
12/02/1999CA2329072A1 Human transmembrane proteins
12/02/1999CA2329056A1 Cell cycle genes, proteins and uses thereof
12/02/1999CA2329053A1 Human socs proteins
12/02/1999CA2329052A1 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
12/02/1999CA2328905A1 Prostate growth-associated membrane proteins
12/02/1999CA2328902A1 Novel secreted and membrane-associated proteins and uses therefor
12/02/1999CA2328892A1 Tumor suppressor
12/02/1999CA2328525A1 Modification of cereal grain hardness via expression of puroindoline proteins
12/02/1999CA2328491A1 Retroviral delivery system
12/02/1999CA2328451A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4
12/02/1999CA2328134A1 The induction of antibiotic proteins and peptides by lait/scd14-protein
12/02/1999CA2317697A1 Agent and method for modulation of cell migration
12/02/1999CA2298070A1 Gene sequences of rubella virus associated with attenuation
12/02/1999CA2234420A1 Methods for the detection, treatment, and prevention of neurodegeneration
12/01/1999EP0960942A2 Targeted delivery through a cationic amino acid transporter
12/01/1999EP0960941A1 Gene Therapy for cell proliferative diseases
12/01/1999EP0960939A2 Dual-tagged proteins and their uses
12/01/1999EP0960937A1 Novel semaphorin gene: semaphorin y
12/01/1999EP0960935A1 Novel mouse cxc chemokine receptor
12/01/1999EP0960888A1 Novel semaphorin genes (i)
12/01/1999EP0960887A1 T cell epitope peptide
12/01/1999EP0960886A1 Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
12/01/1999EP0960339A1 Assay for collagen type ii fragments
12/01/1999EP0960338A1 Diagnostic methods and compositions based on the distribution of rad51
12/01/1999EP0960336A1 Peptide reagent for the detection of human cytomegalovirus (cmv)
12/01/1999EP0960335A2 Modulators of insulin receptor activity
12/01/1999EP0960334A1 Vegf-b/receptor complex and uses thereof
12/01/1999EP0960209A1 Editing-based selectable plastid marker genes
12/01/1999EP0960205A1 Chain reaction cloning
12/01/1999EP0960204A1 Method and reagents for genetic immunization
12/01/1999EP0960202A1 Monocyte chemotactic protein 5 (mcp-5) molecules and uses therefor
12/01/1999EP0960201A1 Mammalian ribonuclease inhibitors and use thereof
12/01/1999EP0960200A1 Transcripts encoding immunomodulatory polypeptides
12/01/1999EP0960199A2 Secreted proteins and polynucleotides encoding them
12/01/1999EP0960198A1 Cd44-like protein
12/01/1999EP0960197A1 GENES FROM 20q13 AMPLICON AND THEIR USES
12/01/1999EP0960196A1 Novel receptor that causes cell death
12/01/1999EP0960193A1 ISOLATION AND CLONING OF THE HUMAN hARSA-I GENE AND USES THEREOF
12/01/1999EP0960191A1 Compositions and methods for use of defensin
12/01/1999EP0960130A1 Oxygen-binding heme proteins incorporating circularly-permuted globins
12/01/1999EP0960129A1 MELATONIN 1a RECEPTOR GENE REGULATORY REGIONS AND USES THEREOF
12/01/1999EP0960128A1 Gene product over expressed in cancer cells
12/01/1999EP0960127A1 Isolated dimeric fibroblast activation protein alpha, and uses thereof
12/01/1999EP0960126A1 Compositions and uses for sentrin, a cell-death protecting protein
12/01/1999EP0960125A1 GALANIN RECEPTOR GalR2 AND NUCLEOTIDES ENCODING SAME
12/01/1999EP0960124A1 Serine substituted mutants of bcl-xl/bcl-2 associated cell death regulator